Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Ischemia | 73 | 2024 | 2145 | 10.450 |
Why?
|
Coronary Artery Disease | 92 | 2024 | 6454 | 7.990 |
Why?
|
Myocardial Revascularization | 41 | 2023 | 841 | 5.880 |
Why?
|
Angioplasty, Balloon, Coronary | 56 | 2021 | 1873 | 5.810 |
Why?
|
Myocardial Infarction | 131 | 2024 | 11690 | 4.870 |
Why?
|
Angina Pectoris | 42 | 2023 | 977 | 4.830 |
Why?
|
Coronary Artery Bypass | 47 | 2023 | 2281 | 4.730 |
Why?
|
Cardiovascular Agents | 34 | 2022 | 848 | 3.950 |
Why?
|
Niacin | 13 | 2019 | 116 | 3.650 |
Why?
|
Cholesterol, HDL | 20 | 2023 | 1813 | 3.250 |
Why?
|
Hypolipidemic Agents | 16 | 2019 | 604 | 3.250 |
Why?
|
Angina, Unstable | 33 | 2022 | 926 | 3.120 |
Why?
|
Coronary Disease | 50 | 2023 | 6078 | 2.620 |
Why?
|
Hypertriglyceridemia | 6 | 2024 | 293 | 2.610 |
Why?
|
Acute Coronary Syndrome | 28 | 2022 | 2337 | 2.530 |
Why?
|
Platelet Aggregation Inhibitors | 35 | 2021 | 3067 | 2.340 |
Why?
|
Electrocardiography | 72 | 2018 | 6440 | 2.020 |
Why?
|
Dyslipidemias | 7 | 2022 | 848 | 1.950 |
Why?
|
Cardiovascular Diseases | 36 | 2024 | 15108 | 1.890 |
Why?
|
Coronary Angiography | 48 | 2022 | 4567 | 1.810 |
Why?
|
Calcium Channel Blockers | 16 | 2020 | 689 | 1.710 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 20 | 2024 | 3239 | 1.580 |
Why?
|
Diltiazem | 21 | 2001 | 133 | 1.570 |
Why?
|
Vasodilator Agents | 12 | 2017 | 976 | 1.570 |
Why?
|
Ischemia | 16 | 2023 | 1911 | 1.550 |
Why?
|
Eicosapentaenoic Acid | 8 | 2024 | 582 | 1.510 |
Why?
|
Myocardial Perfusion Imaging | 9 | 2022 | 555 | 1.400 |
Why?
|
Nitrates | 8 | 2017 | 265 | 1.340 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 9 | 2019 | 1107 | 1.340 |
Why?
|
Adrenergic beta-Antagonists | 23 | 2020 | 1239 | 1.340 |
Why?
|
Coronary Vessels | 12 | 2022 | 3099 | 1.270 |
Why?
|
Exercise Test | 26 | 2020 | 2075 | 1.250 |
Why?
|
Randomized Controlled Trials as Topic | 43 | 2022 | 9941 | 1.250 |
Why?
|
Drug-Eluting Stents | 7 | 2016 | 753 | 1.200 |
Why?
|
Ticlopidine | 15 | 2016 | 899 | 1.160 |
Why?
|
Triglycerides | 14 | 2024 | 2450 | 1.160 |
Why?
|
Humans | 392 | 2024 | 742088 | 1.140 |
Why?
|
Coronary Stenosis | 10 | 2018 | 834 | 1.100 |
Why?
|
Treatment Outcome | 104 | 2024 | 62966 | 1.100 |
Why?
|
Atherosclerosis | 14 | 2024 | 3428 | 1.080 |
Why?
|
Thrombolytic Therapy | 13 | 2018 | 2161 | 0.990 |
Why?
|
Hyperlipidemias | 4 | 2024 | 786 | 0.980 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 11 | 2011 | 641 | 0.930 |
Why?
|
Nitroglycerin | 3 | 2015 | 325 | 0.900 |
Why?
|
Risk Assessment | 43 | 2020 | 23320 | 0.870 |
Why?
|
Drug Therapy, Combination | 33 | 2018 | 6483 | 0.860 |
Why?
|
Fractional Flow Reserve, Myocardial | 3 | 2022 | 279 | 0.860 |
Why?
|
Aspirin | 16 | 2018 | 3278 | 0.860 |
Why?
|
Fibrinolytic Agents | 9 | 2014 | 2156 | 0.830 |
Why?
|
Vasodilation | 2 | 2017 | 944 | 0.820 |
Why?
|
Secondary Prevention | 10 | 2018 | 1520 | 0.800 |
Why?
|
Coronary Circulation | 5 | 2021 | 1572 | 0.800 |
Why?
|
Practice Guidelines as Topic | 25 | 2019 | 7276 | 0.760 |
Why?
|
Diabetes Mellitus | 9 | 2023 | 5724 | 0.760 |
Why?
|
Cholesterol, LDL | 14 | 2023 | 2354 | 0.760 |
Why?
|
Clinical Trials as Topic | 22 | 2022 | 7901 | 0.730 |
Why?
|
Renal Insufficiency, Chronic | 10 | 2022 | 2195 | 0.730 |
Why?
|
Translating | 1 | 2020 | 143 | 0.700 |
Why?
|
Stents | 12 | 2021 | 3276 | 0.700 |
Why?
|
Coronary Occlusion | 1 | 2023 | 303 | 0.700 |
Why?
|
Disease Management | 6 | 2022 | 2450 | 0.680 |
Why?
|
Risk Factors | 78 | 2023 | 72145 | 0.670 |
Why?
|
Exercise Tolerance | 5 | 2018 | 770 | 0.670 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2019 | 127 | 0.660 |
Why?
|
Vascular Diseases | 3 | 2023 | 1155 | 0.630 |
Why?
|
Delivery of Health Care | 6 | 2021 | 5304 | 0.630 |
Why?
|
Middle Aged | 156 | 2023 | 213127 | 0.620 |
Why?
|
Syndrome | 14 | 2021 | 3248 | 0.620 |
Why?
|
Time Factors | 53 | 2021 | 40054 | 0.620 |
Why?
|
Unnecessary Procedures | 1 | 2021 | 431 | 0.620 |
Why?
|
Aged | 128 | 2023 | 162944 | 0.610 |
Why?
|
Lipoproteins | 3 | 2018 | 876 | 0.600 |
Why?
|
Risk Reduction Behavior | 6 | 2022 | 1123 | 0.590 |
Why?
|
Myocardial Reperfusion | 3 | 2008 | 351 | 0.590 |
Why?
|
Male | 181 | 2024 | 349538 | 0.590 |
Why?
|
Diabetes Mellitus, Type 2 | 14 | 2023 | 11695 | 0.590 |
Why?
|
Anticholesteremic Agents | 8 | 2018 | 979 | 0.580 |
Why?
|
Delayed-Action Preparations | 8 | 2019 | 965 | 0.560 |
Why?
|
Female | 191 | 2024 | 379592 | 0.560 |
Why?
|
Reimbursement Mechanisms | 1 | 2021 | 670 | 0.530 |
Why?
|
Quality of Life | 27 | 2023 | 12730 | 0.520 |
Why?
|
Tyrosine | 4 | 2008 | 1460 | 0.520 |
Why?
|
Thrombosis | 6 | 2018 | 2966 | 0.500 |
Why?
|
Health Care Reform | 2 | 2017 | 1261 | 0.490 |
Why?
|
Insulin | 3 | 2016 | 6575 | 0.480 |
Why?
|
Diabetic Angiopathies | 4 | 2015 | 820 | 0.480 |
Why?
|
Diagnostic Techniques, Cardiovascular | 2 | 2016 | 153 | 0.480 |
Why?
|
Prognosis | 37 | 2021 | 29010 | 0.480 |
Why?
|
Testosterone | 3 | 2023 | 2401 | 0.470 |
Why?
|
Chelation Therapy | 1 | 2013 | 67 | 0.470 |
Why?
|
Heart Rate | 15 | 2018 | 4091 | 0.450 |
Why?
|
Peripheral Arterial Disease | 4 | 2019 | 1184 | 0.450 |
Why?
|
Health Expenditures | 2 | 2019 | 2346 | 0.450 |
Why?
|
Cardiomyopathies | 2 | 2023 | 1912 | 0.450 |
Why?
|
Coronary Restenosis | 3 | 2012 | 424 | 0.440 |
Why?
|
Kaplan-Meier Estimate | 18 | 2020 | 6534 | 0.440 |
Why?
|
Acetanilides | 3 | 2011 | 168 | 0.440 |
Why?
|
Heart Diseases | 4 | 2012 | 2789 | 0.430 |
Why?
|
Androgens | 1 | 2020 | 1271 | 0.430 |
Why?
|
Follow-Up Studies | 41 | 2021 | 39004 | 0.420 |
Why?
|
Cardiology | 6 | 2023 | 1658 | 0.420 |
Why?
|
Combined Modality Therapy | 14 | 2018 | 8621 | 0.420 |
Why?
|
Chelating Agents | 1 | 2013 | 380 | 0.420 |
Why?
|
Hypoglycemic Agents | 5 | 2019 | 2866 | 0.420 |
Why?
|
Glucose Intolerance | 1 | 2016 | 577 | 0.400 |
Why?
|
Multicenter Studies as Topic | 10 | 2010 | 1661 | 0.400 |
Why?
|
Double-Blind Method | 25 | 2023 | 12017 | 0.400 |
Why?
|
Coronary Care Units | 4 | 2008 | 214 | 0.400 |
Why?
|
Survival Rate | 16 | 2021 | 12773 | 0.400 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1499 | 0.390 |
Why?
|
Piperazines | 6 | 2013 | 2488 | 0.390 |
Why?
|
Verapamil | 3 | 2001 | 244 | 0.380 |
Why?
|
Severity of Illness Index | 22 | 2020 | 15530 | 0.380 |
Why?
|
Cause of Death | 6 | 2019 | 3571 | 0.370 |
Why?
|
Lipoproteins, HDL | 5 | 2018 | 637 | 0.370 |
Why?
|
Goals | 2 | 2024 | 705 | 0.360 |
Why?
|
Endpoint Determination | 5 | 2011 | 600 | 0.360 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 8 | 2019 | 1517 | 0.350 |
Why?
|
Simvastatin | 6 | 2019 | 360 | 0.350 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1887 | 0.350 |
Why?
|
Ventricular Dysfunction, Left | 8 | 2023 | 2059 | 0.340 |
Why?
|
Perioperative Care | 2 | 2017 | 997 | 0.330 |
Why?
|
Gemfibrozil | 4 | 2003 | 30 | 0.330 |
Why?
|
Anticoagulants | 6 | 2009 | 4595 | 0.330 |
Why?
|
Coronary Thrombosis | 4 | 2011 | 494 | 0.330 |
Why?
|
Creatine Kinase | 15 | 2024 | 694 | 0.330 |
Why?
|
Stroke | 21 | 2023 | 9963 | 0.320 |
Why?
|
Tachycardia, Supraventricular | 1 | 2011 | 263 | 0.320 |
Why?
|
Cost-Benefit Analysis | 11 | 2023 | 5385 | 0.320 |
Why?
|
Health Status | 11 | 2023 | 4030 | 0.320 |
Why?
|
Predictive Value of Tests | 17 | 2022 | 15056 | 0.320 |
Why?
|
Echocardiography, Stress | 4 | 2015 | 131 | 0.320 |
Why?
|
United States | 37 | 2023 | 69693 | 0.310 |
Why?
|
Drugs, Investigational | 1 | 2010 | 214 | 0.310 |
Why?
|
Physician-Patient Relations | 1 | 2021 | 3215 | 0.310 |
Why?
|
Hospitals, Veterans | 4 | 2002 | 404 | 0.300 |
Why?
|
Fibrinolysis | 2 | 2007 | 322 | 0.290 |
Why?
|
Exercise Therapy | 1 | 2014 | 904 | 0.290 |
Why?
|
Laboratories | 1 | 2011 | 461 | 0.290 |
Why?
|
Patient Admission | 3 | 2013 | 1380 | 0.290 |
Why?
|
Stroke Volume | 7 | 2016 | 4983 | 0.290 |
Why?
|
Hyperglycemia | 2 | 2013 | 1368 | 0.280 |
Why?
|
Survival Analysis | 18 | 2020 | 10248 | 0.280 |
Why?
|
Hypogonadism | 2 | 2023 | 798 | 0.280 |
Why?
|
Enzyme Inhibitors | 5 | 2014 | 3800 | 0.280 |
Why?
|
Decision Trees | 4 | 2020 | 506 | 0.270 |
Why?
|
Registries | 6 | 2021 | 8077 | 0.270 |
Why?
|
Heart Conduction System | 2 | 2001 | 1048 | 0.270 |
Why?
|
Guideline Adherence | 7 | 2019 | 2266 | 0.270 |
Why?
|
Postoperative Complications | 7 | 2017 | 15244 | 0.270 |
Why?
|
Digoxin | 3 | 2000 | 250 | 0.270 |
Why?
|
United States Department of Veterans Affairs | 7 | 2022 | 874 | 0.260 |
Why?
|
Television | 1 | 2008 | 409 | 0.260 |
Why?
|
Angiotensin Receptor Antagonists | 3 | 2021 | 923 | 0.260 |
Why?
|
Hypertension | 10 | 2023 | 8455 | 0.260 |
Why?
|
Tachycardia, Ventricular | 2 | 2011 | 1272 | 0.250 |
Why?
|
Recurrence | 18 | 2018 | 8333 | 0.250 |
Why?
|
Anti-Arrhythmia Agents | 4 | 2017 | 790 | 0.240 |
Why?
|
Thiophenes | 3 | 2013 | 590 | 0.240 |
Why?
|
Microcirculation | 1 | 2009 | 1285 | 0.240 |
Why?
|
Vascular Surgical Procedures | 2 | 2023 | 1473 | 0.230 |
Why?
|
Government Regulation | 1 | 2008 | 522 | 0.230 |
Why?
|
History, 21st Century | 4 | 2018 | 1533 | 0.230 |
Why?
|
Antihypertensive Agents | 3 | 2019 | 2043 | 0.220 |
Why?
|
Acute Disease | 13 | 2005 | 7141 | 0.220 |
Why?
|
Evidence-Based Medicine | 7 | 2017 | 3611 | 0.210 |
Why?
|
Lipids | 2 | 2009 | 3302 | 0.210 |
Why?
|
Insurance, Health | 2 | 2019 | 2493 | 0.210 |
Why?
|
Incidence | 12 | 2021 | 20928 | 0.210 |
Why?
|
Glomerular Filtration Rate | 2 | 2021 | 2167 | 0.210 |
Why?
|
Blood Glucose | 2 | 2016 | 6249 | 0.210 |
Why?
|
Prospective Studies | 25 | 2023 | 53187 | 0.210 |
Why?
|
Heart Failure | 9 | 2023 | 10856 | 0.210 |
Why?
|
Hospitals, Urban | 1 | 2004 | 499 | 0.210 |
Why?
|
Cardiology Service, Hospital | 1 | 2004 | 246 | 0.210 |
Why?
|
Proportional Hazards Models | 15 | 2020 | 12344 | 0.210 |
Why?
|
Hemorrhage | 8 | 2018 | 3461 | 0.210 |
Why?
|
Hippocratic Oath | 1 | 2021 | 16 | 0.200 |
Why?
|
Aged, 80 and over | 21 | 2023 | 57683 | 0.200 |
Why?
|
History, 20th Century | 4 | 2018 | 2739 | 0.200 |
Why?
|
Comorbidity | 11 | 2019 | 10372 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2021 | 10943 | 0.190 |
Why?
|
Drug Therapy | 2 | 2010 | 497 | 0.190 |
Why?
|
Felodipine | 2 | 1997 | 3 | 0.180 |
Why?
|
Phenethylamines | 1 | 2000 | 101 | 0.180 |
Why?
|
Peptides | 4 | 2008 | 4392 | 0.170 |
Why?
|
Blood Platelets | 1 | 2010 | 2506 | 0.170 |
Why?
|
Referral and Consultation | 3 | 2022 | 3527 | 0.170 |
Why?
|
Brugada Syndrome | 2 | 2011 | 97 | 0.170 |
Why?
|
Risk | 8 | 2018 | 9679 | 0.170 |
Why?
|
Cardiomegaly | 3 | 1992 | 619 | 0.160 |
Why?
|
Preventive Medicine | 2 | 2017 | 263 | 0.160 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 281 | 0.160 |
Why?
|
Immunoglobulin Fab Fragments | 3 | 2008 | 482 | 0.160 |
Why?
|
Research Design | 8 | 2019 | 5979 | 0.160 |
Why?
|
Exercise | 4 | 2018 | 5611 | 0.160 |
Why?
|
Isoenzymes | 11 | 2005 | 1725 | 0.160 |
Why?
|
Troponin | 4 | 2011 | 524 | 0.160 |
Why?
|
Creatine Kinase, MB Form | 3 | 2020 | 214 | 0.160 |
Why?
|
Data Interpretation, Statistical | 2 | 2007 | 2714 | 0.160 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 12958 | 0.160 |
Why?
|
Veterans | 5 | 2022 | 2513 | 0.160 |
Why?
|
Chronic Disease | 8 | 2024 | 9144 | 0.160 |
Why?
|
Sodium Channel Blockers | 1 | 2019 | 176 | 0.160 |
Why?
|
Enalapril | 2 | 1997 | 327 | 0.150 |
Why?
|
Hospitals | 1 | 2011 | 3937 | 0.150 |
Why?
|
Hormone Replacement Therapy | 1 | 2023 | 744 | 0.150 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2023 | 532 | 0.150 |
Why?
|
Thoracic Surgery | 1 | 2024 | 713 | 0.150 |
Why?
|
Cohort Studies | 10 | 2023 | 40450 | 0.150 |
Why?
|
Blood Pressure | 10 | 2019 | 8541 | 0.150 |
Why?
|
Coronary Sinus | 1 | 2017 | 87 | 0.150 |
Why?
|
Health Services Misuse | 1 | 2019 | 243 | 0.150 |
Why?
|
Oxygen Consumption | 2 | 2017 | 1869 | 0.140 |
Why?
|
Outpatients | 2 | 2021 | 1483 | 0.140 |
Why?
|
Cardiopulmonary Bypass | 1 | 2001 | 1066 | 0.140 |
Why?
|
Life Style | 4 | 2019 | 3824 | 0.140 |
Why?
|
Internationality | 1 | 2022 | 1002 | 0.140 |
Why?
|
Brain Ischemia | 4 | 2018 | 3258 | 0.140 |
Why?
|
Hospital Mortality | 6 | 2013 | 5310 | 0.140 |
Why?
|
Administration, Sublingual | 1 | 2015 | 56 | 0.130 |
Why?
|
Canada | 6 | 2015 | 2061 | 0.130 |
Why?
|
Disease Progression | 6 | 2011 | 13256 | 0.130 |
Why?
|
Age Factors | 9 | 2019 | 18355 | 0.130 |
Why?
|
Brachiocephalic Veins | 1 | 2015 | 23 | 0.130 |
Why?
|
Meta-Analysis as Topic | 3 | 2001 | 1342 | 0.130 |
Why?
|
Odds Ratio | 6 | 2016 | 9846 | 0.130 |
Why?
|
Ontario | 1 | 2016 | 381 | 0.130 |
Why?
|
Benzazepines | 3 | 1986 | 326 | 0.130 |
Why?
|
Tablets | 1 | 2015 | 147 | 0.130 |
Why?
|
Azetidines | 2 | 2013 | 142 | 0.130 |
Why?
|
Haptoglobins | 1 | 2016 | 165 | 0.130 |
Why?
|
Resource Allocation | 1 | 2017 | 341 | 0.130 |
Why?
|
Bioprosthesis | 2 | 1994 | 596 | 0.130 |
Why?
|
Adult | 43 | 2023 | 213712 | 0.130 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 425 | 0.130 |
Why?
|
Chemistry, Pharmaceutical | 2 | 2015 | 282 | 0.130 |
Why?
|
Clinical Protocols | 5 | 2019 | 1459 | 0.130 |
Why?
|
North America | 4 | 2013 | 1249 | 0.120 |
Why?
|
Medicare | 1 | 2013 | 6532 | 0.120 |
Why?
|
Health Care Costs | 2 | 2023 | 3203 | 0.120 |
Why?
|
Chi-Square Distribution | 5 | 2013 | 3510 | 0.120 |
Why?
|
Cardiac Care Facilities | 2 | 2011 | 35 | 0.120 |
Why?
|
Sex Factors | 6 | 2020 | 10392 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2021 | 827 | 0.120 |
Why?
|
Medical History Taking | 2 | 2015 | 783 | 0.120 |
Why?
|
Medication Adherence | 3 | 2022 | 2055 | 0.120 |
Why?
|
Cholesterol | 2 | 2013 | 2895 | 0.120 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 1999 | 859 | 0.120 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 1415 | 0.120 |
Why?
|
Retrospective Studies | 23 | 2021 | 77098 | 0.120 |
Why?
|
Echocardiography | 4 | 2022 | 5097 | 0.110 |
Why?
|
Pericarditis | 2 | 1985 | 128 | 0.110 |
Why?
|
Aerosols | 1 | 2015 | 623 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 2 | 2018 | 1541 | 0.110 |
Why?
|
Apolipoprotein A-II | 1 | 1992 | 39 | 0.110 |
Why?
|
Angioplasty | 2 | 2015 | 364 | 0.110 |
Why?
|
Connecticut | 2 | 2004 | 363 | 0.110 |
Why?
|
Early Diagnosis | 2 | 2015 | 1184 | 0.110 |
Why?
|
Societies, Scientific | 1 | 2013 | 220 | 0.110 |
Why?
|
Patient Transfer | 3 | 2008 | 760 | 0.100 |
Why?
|
Multivariate Analysis | 7 | 2016 | 12242 | 0.100 |
Why?
|
Diabetes Complications | 3 | 2011 | 1359 | 0.100 |
Why?
|
Polysaccharides | 2 | 2009 | 1051 | 0.100 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1995 | 476 | 0.100 |
Why?
|
Pacemaker, Artificial | 2 | 2010 | 817 | 0.100 |
Why?
|
Streptokinase | 1 | 1991 | 188 | 0.100 |
Why?
|
Physician Executives | 1 | 2012 | 128 | 0.100 |
Why?
|
Myocardium | 4 | 2017 | 4775 | 0.100 |
Why?
|
Communication Barriers | 1 | 2014 | 398 | 0.100 |
Why?
|
Radionuclide Ventriculography | 3 | 2002 | 41 | 0.100 |
Why?
|
Hospitals, Community | 3 | 2008 | 348 | 0.090 |
Why?
|
Heart Valve Prosthesis | 2 | 1994 | 1486 | 0.090 |
Why?
|
Apolipoproteins B | 1 | 1992 | 373 | 0.090 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12220 | 0.090 |
Why?
|
Sulfonamides | 1 | 2000 | 1932 | 0.090 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 1994 | 346 | 0.090 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2013 | 361 | 0.090 |
Why?
|
Prevalence | 6 | 2019 | 15194 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2572 | 0.090 |
Why?
|
Enoxaparin | 2 | 2009 | 377 | 0.090 |
Why?
|
Baltimore | 1 | 2010 | 231 | 0.090 |
Why?
|
Recovery of Function | 2 | 2018 | 2924 | 0.090 |
Why?
|
Hospital Units | 1 | 2011 | 141 | 0.090 |
Why?
|
Pyridines | 3 | 2018 | 2818 | 0.090 |
Why?
|
Renal Dialysis | 2 | 2018 | 1780 | 0.090 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2014 | 453 | 0.090 |
Why?
|
Bayes Theorem | 3 | 2022 | 2303 | 0.090 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2010 | 293 | 0.090 |
Why?
|
Physical Examination | 1 | 2015 | 1239 | 0.090 |
Why?
|
Decision Making | 2 | 2017 | 3869 | 0.080 |
Why?
|
Adenosine Diphosphate | 1 | 2010 | 425 | 0.080 |
Why?
|
Prostaglandins | 1 | 2010 | 405 | 0.080 |
Why?
|
Atrioventricular Block | 1 | 2010 | 120 | 0.080 |
Why?
|
Health Literacy | 1 | 2014 | 414 | 0.080 |
Why?
|
Platelet Function Tests | 1 | 2010 | 270 | 0.080 |
Why?
|
Angiotensins | 1 | 2009 | 151 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3526 | 0.080 |
Why?
|
Nifedipine | 2 | 1988 | 226 | 0.080 |
Why?
|
Labor, Obstetric | 6 | 1968 | 333 | 0.080 |
Why?
|
Parasympathetic Nervous System | 1 | 1989 | 141 | 0.080 |
Why?
|
Xanthophylls | 1 | 2008 | 96 | 0.080 |
Why?
|
Logistic Models | 5 | 2016 | 13403 | 0.080 |
Why?
|
Medically Uninsured | 1 | 2014 | 852 | 0.080 |
Why?
|
Tachycardia | 1 | 2011 | 620 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2018 | 2536 | 0.080 |
Why?
|
Health Behavior | 2 | 2018 | 2630 | 0.080 |
Why?
|
Physical Fitness | 1 | 2013 | 732 | 0.080 |
Why?
|
Patient Selection | 3 | 2009 | 4214 | 0.080 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2010 | 434 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1952 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 3 | 2023 | 1679 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 1 | 2013 | 783 | 0.080 |
Why?
|
Linear Models | 3 | 2016 | 5948 | 0.070 |
Why?
|
Myocardial Contraction | 5 | 1984 | 1585 | 0.070 |
Why?
|
American Heart Association | 2 | 2009 | 1055 | 0.070 |
Why?
|
Animals | 12 | 2019 | 168561 | 0.070 |
Why?
|
Pulmonary Gas Exchange | 1 | 2009 | 381 | 0.070 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1668 | 0.070 |
Why?
|
Platelet Aggregation | 1 | 2010 | 800 | 0.070 |
Why?
|
Hypercholesterolemia | 2 | 2013 | 1149 | 0.070 |
Why?
|
Random Allocation | 8 | 1989 | 2425 | 0.070 |
Why?
|
Causality | 1 | 2013 | 1265 | 0.070 |
Why?
|
Heart Neoplasms | 3 | 1987 | 374 | 0.070 |
Why?
|
Sympathetic Nervous System | 1 | 1989 | 514 | 0.070 |
Why?
|
Radiography | 2 | 2016 | 7010 | 0.070 |
Why?
|
Emergency Medical Services | 2 | 2008 | 1914 | 0.070 |
Why?
|
Constriction, Pathologic | 3 | 2022 | 1095 | 0.070 |
Why?
|
Drug Administration Schedule | 4 | 2016 | 4929 | 0.070 |
Why?
|
Heart Rupture | 1 | 1985 | 23 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2019 | 4440 | 0.070 |
Why?
|
Endothelium, Vascular | 2 | 2008 | 4455 | 0.070 |
Why?
|
Defibrillators, Implantable | 1 | 2015 | 1440 | 0.070 |
Why?
|
Kidney | 2 | 2022 | 7167 | 0.070 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2007 | 339 | 0.070 |
Why?
|
Technetium Tc 99m Sestamibi | 2 | 2004 | 176 | 0.070 |
Why?
|
Length of Stay | 5 | 2021 | 6294 | 0.070 |
Why?
|
Statistics as Topic | 1 | 1992 | 2372 | 0.060 |
Why?
|
Models, Statistical | 1 | 2020 | 5100 | 0.060 |
Why?
|
Uterus | 5 | 1968 | 710 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2014 | 3656 | 0.060 |
Why?
|
Social Class | 1 | 2014 | 1995 | 0.060 |
Why?
|
Antifibrinolytic Agents | 1 | 2007 | 254 | 0.060 |
Why?
|
Hospitalization | 7 | 2016 | 10232 | 0.060 |
Why?
|
Heart Ventricles | 4 | 2013 | 3801 | 0.060 |
Why?
|
Blood Transfusion | 3 | 2008 | 1296 | 0.060 |
Why?
|
Consensus | 1 | 2013 | 2935 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2451 | 0.060 |
Why?
|
Chest Pain | 1 | 2011 | 1113 | 0.060 |
Why?
|
Physical Exertion | 1 | 1987 | 695 | 0.060 |
Why?
|
Bezafibrate | 1 | 2003 | 14 | 0.060 |
Why?
|
Japan | 1 | 2008 | 1360 | 0.060 |
Why?
|
Peripheral Vascular Diseases | 1 | 2007 | 550 | 0.060 |
Why?
|
Ibuprofen | 1 | 1985 | 235 | 0.060 |
Why?
|
Anniversaries and Special Events | 1 | 2004 | 89 | 0.060 |
Why?
|
Reproducibility of Results | 6 | 2018 | 19862 | 0.060 |
Why?
|
Water-Electrolyte Balance | 1 | 2004 | 346 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2021 | 5062 | 0.060 |
Why?
|
Transdermal Patch | 1 | 2023 | 51 | 0.060 |
Why?
|
Coronary Aneurysm | 1 | 2006 | 237 | 0.060 |
Why?
|
Puerperal Disorders | 1 | 2006 | 275 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2009 | 2970 | 0.060 |
Why?
|
Antibodies, Monoclonal | 3 | 2008 | 9274 | 0.060 |
Why?
|
Lovastatin | 1 | 2003 | 120 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3862 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1675 | 0.050 |
Why?
|
Endocarditis | 2 | 1987 | 348 | 0.050 |
Why?
|
Diatrizoate | 1 | 1982 | 86 | 0.050 |
Why?
|
Laboratories, Hospital | 1 | 2004 | 194 | 0.050 |
Why?
|
New York | 2 | 2019 | 886 | 0.050 |
Why?
|
Cryptococcosis | 1 | 1983 | 101 | 0.050 |
Why?
|
Thallium Radioisotopes | 2 | 2002 | 139 | 0.050 |
Why?
|
Gels | 1 | 2023 | 427 | 0.050 |
Why?
|
Perfusion | 1 | 2006 | 1359 | 0.050 |
Why?
|
Heart | 5 | 2023 | 4462 | 0.050 |
Why?
|
Angina Pectoris, Variant | 1 | 1981 | 55 | 0.050 |
Why?
|
Collagen | 1 | 2010 | 2684 | 0.050 |
Why?
|
History, 19th Century | 1 | 2004 | 720 | 0.050 |
Why?
|
Benchmarking | 1 | 2008 | 1038 | 0.050 |
Why?
|
Health Education | 1 | 2008 | 1053 | 0.050 |
Why?
|
Leg | 2 | 2005 | 1110 | 0.050 |
Why?
|
Self Care | 1 | 2006 | 786 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17400 | 0.050 |
Why?
|
Time | 1 | 2002 | 530 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2023 | 20086 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1562 | 0.050 |
Why?
|
Quality of Health Care | 4 | 2009 | 4369 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2008 | 6891 | 0.050 |
Why?
|
Fluid Therapy | 1 | 2004 | 592 | 0.050 |
Why?
|
Health Promotion | 1 | 2013 | 2194 | 0.050 |
Why?
|
Inpatients | 1 | 2012 | 2495 | 0.050 |
Why?
|
Acetates | 1 | 2001 | 312 | 0.050 |
Why?
|
Radionuclide Imaging | 5 | 2011 | 2027 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2019 | 21719 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1581 | 0.050 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 475 | 0.040 |
Why?
|
Dystocia | 3 | 1968 | 34 | 0.040 |
Why?
|
Contrast Media | 2 | 2004 | 5295 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2010 | 5975 | 0.040 |
Why?
|
State Medicine | 1 | 2021 | 220 | 0.040 |
Why?
|
Cross-Over Studies | 3 | 2013 | 2030 | 0.040 |
Why?
|
Patient Satisfaction | 4 | 2013 | 3391 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3471 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 174 | 0.040 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 653 | 0.040 |
Why?
|
Cardiac Complexes, Premature | 1 | 1978 | 64 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 333 | 0.040 |
Why?
|
Ambulatory Care | 1 | 2009 | 2706 | 0.040 |
Why?
|
Hemangioma | 1 | 1983 | 737 | 0.040 |
Why?
|
Critical Pathways | 1 | 2002 | 475 | 0.040 |
Why?
|
Michigan | 1 | 2019 | 350 | 0.040 |
Why?
|
Denmark | 1 | 2000 | 736 | 0.040 |
Why?
|
Smoking Cessation | 3 | 2018 | 2068 | 0.040 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2004 | 851 | 0.040 |
Why?
|
Systole | 1 | 1980 | 956 | 0.040 |
Why?
|
New Zealand | 1 | 2018 | 357 | 0.040 |
Why?
|
Florida | 1 | 2019 | 435 | 0.040 |
Why?
|
Program Development | 1 | 2004 | 1314 | 0.040 |
Why?
|
Pulmonary Edema | 1 | 2000 | 415 | 0.040 |
Why?
|
Arrhythmias, Cardiac | 3 | 2018 | 2267 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2008 | 3081 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2019 | 475 | 0.040 |
Why?
|
Brucella Vaccine | 2 | 1967 | 3 | 0.040 |
Why?
|
Femoral Artery | 1 | 2001 | 843 | 0.040 |
Why?
|
Brucella abortus | 2 | 1967 | 12 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2004 | 983 | 0.040 |
Why?
|
Uterine Cervical Diseases | 2 | 1967 | 77 | 0.040 |
Why?
|
Algorithms | 5 | 2014 | 13853 | 0.040 |
Why?
|
Retreatment | 1 | 2018 | 604 | 0.040 |
Why?
|
Mass Screening | 1 | 2012 | 5238 | 0.040 |
Why?
|
Republic of Korea | 1 | 2018 | 538 | 0.030 |
Why?
|
Cardiac Output | 2 | 1981 | 853 | 0.030 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2017 | 364 | 0.030 |
Why?
|
Suture Techniques | 1 | 2001 | 797 | 0.030 |
Why?
|
Hypotension | 1 | 1982 | 880 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2006 | 2633 | 0.030 |
Why?
|
Hemodynamics | 4 | 1997 | 4197 | 0.030 |
Why?
|
Smoking | 4 | 2018 | 8969 | 0.030 |
Why?
|
Myocardial Stunning | 1 | 1995 | 68 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 269 | 0.030 |
Why?
|
Hospital Costs | 1 | 2002 | 980 | 0.030 |
Why?
|
Lactones | 1 | 2018 | 329 | 0.030 |
Why?
|
Calibration | 1 | 2018 | 815 | 0.030 |
Why?
|
Dextropropoxyphene | 2 | 1966 | 26 | 0.030 |
Why?
|
Sweden | 1 | 2018 | 1343 | 0.030 |
Why?
|
Patient Discharge | 1 | 2008 | 3300 | 0.030 |
Why?
|
Drug Interactions | 1 | 2000 | 1458 | 0.030 |
Why?
|
Myxoma | 2 | 1987 | 130 | 0.030 |
Why?
|
Subcutaneous Tissue | 1 | 2015 | 135 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2009 | 4246 | 0.030 |
Why?
|
Forecasting | 1 | 2003 | 2948 | 0.030 |
Why?
|
Respiration | 2 | 1989 | 1645 | 0.030 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2004 | 1527 | 0.030 |
Why?
|
Atrial Fibrillation | 2 | 2004 | 5019 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 2017 | 1423 | 0.030 |
Why?
|
Sex Distribution | 2 | 2009 | 2295 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2024 | 2585 | 0.030 |
Why?
|
Age Distribution | 1 | 1999 | 2900 | 0.030 |
Why?
|
Drug Utilization | 1 | 2019 | 1181 | 0.030 |
Why?
|
Diuretics | 1 | 1996 | 591 | 0.030 |
Why?
|
Regression Analysis | 3 | 2013 | 6452 | 0.030 |
Why?
|
Cardiotonic Agents | 1 | 1996 | 535 | 0.030 |
Why?
|
Body Mass Index | 5 | 2010 | 12695 | 0.030 |
Why?
|
Heparin | 2 | 2008 | 1636 | 0.030 |
Why?
|
Research | 1 | 2001 | 1999 | 0.030 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2012 | 71 | 0.030 |
Why?
|
Oxytocin | 2 | 1967 | 395 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2018 | 802 | 0.030 |
Why?
|
Drug Packaging | 1 | 1972 | 39 | 0.030 |
Why?
|
Discriminant Analysis | 1 | 2012 | 235 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2002 | 2658 | 0.030 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2015 | 277 | 0.030 |
Why?
|
Electric Countershock | 1 | 2015 | 535 | 0.030 |
Why?
|
Ankle Brachial Index | 1 | 2012 | 154 | 0.030 |
Why?
|
Anesthesia, Obstetrical | 2 | 1965 | 235 | 0.030 |
Why?
|
Treatment Failure | 2 | 2011 | 2615 | 0.020 |
Why?
|
Obstetric Labor, Premature | 2 | 1970 | 279 | 0.020 |
Why?
|
Ethylamines | 1 | 1970 | 17 | 0.020 |
Why?
|
Amino Alcohols | 1 | 1970 | 16 | 0.020 |
Why?
|
Drug Evaluation | 1 | 1992 | 637 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 1991 | 1420 | 0.020 |
Why?
|
Analgesics | 3 | 1968 | 1037 | 0.020 |
Why?
|
Lung Diseases | 1 | 2001 | 1884 | 0.020 |
Why?
|
Sympatholytics | 1 | 1970 | 83 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3119 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 2015 | 453 | 0.020 |
Why?
|
Electrodes, Implanted | 1 | 2015 | 824 | 0.020 |
Why?
|
Nomograms | 1 | 2012 | 224 | 0.020 |
Why?
|
Fetus | 2 | 1968 | 1879 | 0.020 |
Why?
|
Thrombectomy | 1 | 2015 | 679 | 0.020 |
Why?
|
Electric Power Supplies | 1 | 2010 | 99 | 0.020 |
Why?
|
Intermittent Claudication | 1 | 2012 | 309 | 0.020 |
Why?
|
Scopolamine | 1 | 1990 | 99 | 0.020 |
Why?
|
Catheterization | 1 | 2015 | 1468 | 0.020 |
Why?
|
Cineangiography | 1 | 1989 | 124 | 0.020 |
Why?
|
Research Report | 1 | 2012 | 355 | 0.020 |
Why?
|
Telemetry | 1 | 2010 | 205 | 0.020 |
Why?
|
Nicotinic Acids | 1 | 1968 | 31 | 0.020 |
Why?
|
Freeze Drying | 2 | 1967 | 98 | 0.020 |
Why?
|
Antithrombins | 1 | 2011 | 304 | 0.020 |
Why?
|
Isosorbide Dinitrate | 1 | 2008 | 34 | 0.020 |
Why?
|
Vascular Patency | 1 | 1991 | 885 | 0.020 |
Why?
|
Case Management | 1 | 2010 | 286 | 0.020 |
Why?
|
Down-Regulation | 1 | 2016 | 3001 | 0.020 |
Why?
|
Theophylline | 1 | 1968 | 132 | 0.020 |
Why?
|
Europe | 1 | 1995 | 3339 | 0.020 |
Why?
|
Inflammation | 1 | 2008 | 10578 | 0.020 |
Why?
|
Amlodipine | 1 | 2008 | 83 | 0.020 |
Why?
|
Metoprolol | 1 | 2008 | 93 | 0.020 |
Why?
|
Consent Forms | 1 | 2008 | 53 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1794 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2004 | 3336 | 0.020 |
Why?
|
Erysipelothrix | 1 | 1967 | 4 | 0.020 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1737 | 0.020 |
Why?
|
Propensity Score | 1 | 2014 | 1771 | 0.020 |
Why?
|
Levallorphan | 1 | 1967 | 1 | 0.020 |
Why?
|
Microbiology | 1 | 1968 | 72 | 0.020 |
Why?
|
Meperidine | 1 | 1967 | 38 | 0.020 |
Why?
|
Muscular Diseases | 1 | 2011 | 557 | 0.020 |
Why?
|
Dermoid Cyst | 1 | 1967 | 92 | 0.020 |
Why?
|
Probability | 1 | 2012 | 2502 | 0.020 |
Why?
|
Abortion, Habitual | 1 | 1967 | 70 | 0.020 |
Why?
|
Hematocrit | 1 | 2008 | 636 | 0.020 |
Why?
|
Muscles | 2 | 1968 | 1617 | 0.020 |
Why?
|
Lipoproteins, LDL | 1 | 2009 | 628 | 0.020 |
Why?
|
Dogs | 3 | 1981 | 3910 | 0.020 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 1967 | 142 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6259 | 0.020 |
Why?
|
Muscle Contraction | 2 | 1968 | 1241 | 0.020 |
Why?
|
Labor, Induced | 1 | 1967 | 146 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1676 | 0.020 |
Why?
|
Uterine Diseases | 1 | 1967 | 135 | 0.020 |
Why?
|
Prosthesis Implantation | 1 | 2010 | 641 | 0.020 |
Why?
|
Labor Pain | 1 | 1965 | 16 | 0.020 |
Why?
|
Pregnancy | 13 | 2006 | 29087 | 0.020 |
Why?
|
Clinical Enzyme Tests | 1 | 1984 | 115 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1967 | 625 | 0.020 |
Why?
|
Posture | 1 | 1989 | 958 | 0.020 |
Why?
|
Obstetric Labor Complications | 1 | 1967 | 238 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1993 | 6365 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3151 | 0.020 |
Why?
|
Heart Septum | 1 | 1985 | 313 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2008 | 1589 | 0.010 |
Why?
|
Mycoplasma pneumoniae | 1 | 1983 | 43 | 0.010 |
Why?
|
Obesity | 1 | 2006 | 12705 | 0.010 |
Why?
|
Parasympatholytics | 1 | 1963 | 91 | 0.010 |
Why?
|
Pharmacology | 1 | 1963 | 103 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1767 | 0.010 |
Why?
|
Flucytosine | 1 | 1983 | 32 | 0.010 |
Why?
|
Pneumonia, Mycoplasma | 1 | 1983 | 50 | 0.010 |
Why?
|
Heart Atria | 2 | 1987 | 1348 | 0.010 |
Why?
|
Oxytocics | 1 | 1963 | 68 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2019 | 24913 | 0.010 |
Why?
|
Muscle Relaxants, Central | 1 | 1963 | 86 | 0.010 |
Why?
|
Amiodarone | 1 | 2004 | 212 | 0.010 |
Why?
|
Anesthesia | 2 | 1965 | 1548 | 0.010 |
Why?
|
Amphotericin B | 1 | 1983 | 137 | 0.010 |
Why?
|
Streptococcal Infections | 1 | 1987 | 637 | 0.010 |
Why?
|
Pain | 2 | 1968 | 4961 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1364 | 0.010 |
Why?
|
Emergency Treatment | 1 | 2006 | 517 | 0.010 |
Why?
|
Primary Prevention | 1 | 2009 | 1166 | 0.010 |
Why?
|
Dietary Fats | 1 | 2010 | 2017 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2013 | 2723 | 0.010 |
Why?
|
Angiography | 1 | 1987 | 1636 | 0.010 |
Why?
|
Reference Values | 1 | 1989 | 4982 | 0.010 |
Why?
|
Arteries | 1 | 1967 | 1118 | 0.010 |
Why?
|
Women's Health | 1 | 2011 | 2034 | 0.010 |
Why?
|
Complement C4 | 1 | 1982 | 257 | 0.010 |
Why?
|
Documentation | 1 | 1968 | 865 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21821 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12946 | 0.010 |
Why?
|
Early Ambulation | 1 | 2001 | 43 | 0.010 |
Why?
|
Heart Block | 1 | 1983 | 410 | 0.010 |
Why?
|
Motor Activity | 1 | 2011 | 2714 | 0.010 |
Why?
|
Societies, Medical | 1 | 1992 | 3740 | 0.010 |
Why?
|
Equipment Safety | 1 | 2001 | 264 | 0.010 |
Why?
|
Complement C3 | 1 | 1982 | 460 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3766 | 0.010 |
Why?
|
Internet | 1 | 2011 | 3062 | 0.010 |
Why?
|
Mortality | 1 | 2010 | 2857 | 0.010 |
Why?
|
Pulse | 2 | 1970 | 229 | 0.010 |
Why?
|
Equipment Failure Analysis | 1 | 2001 | 867 | 0.010 |
Why?
|
Aneurysm, False | 1 | 2001 | 276 | 0.010 |
Why?
|
Anemia | 1 | 2008 | 1499 | 0.010 |
Why?
|
Adolescent | 4 | 2006 | 85649 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1978 | 326 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 1990 | 2623 | 0.010 |
Why?
|
Critical Care | 1 | 2010 | 2640 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 13921 | 0.010 |
Why?
|
Cardiac Volume | 1 | 1978 | 210 | 0.010 |
Why?
|
Obstetrics | 1 | 1963 | 657 | 0.010 |
Why?
|
Hematoma | 1 | 2001 | 755 | 0.010 |
Why?
|
Observer Variation | 1 | 2002 | 2593 | 0.010 |
Why?
|
Emotions | 1 | 1968 | 2657 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 3915 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1980 | 793 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 35342 | 0.010 |
Why?
|
Methods | 2 | 1972 | 1128 | 0.010 |
Why?
|
Physical Endurance | 1 | 1997 | 370 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1967 | 2011 | 0.010 |
Why?
|
Home Care Services | 1 | 1981 | 602 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2004 | 14720 | 0.010 |
Why?
|
Hormones | 1 | 1997 | 884 | 0.010 |
Why?
|
Reoperation | 1 | 1983 | 4200 | 0.010 |
Why?
|
Aortic Valve | 1 | 1983 | 1911 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1967 | 2861 | 0.010 |
Why?
|
Mice | 1 | 2019 | 81045 | 0.010 |
Why?
|
Germany, East | 1 | 1972 | 5 | 0.010 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1538 | 0.010 |
Why?
|
Aorta, Thoracic | 1 | 1978 | 1080 | 0.010 |
Why?
|
Electricity | 1 | 1972 | 182 | 0.010 |
Why?
|
Immune Sera | 1 | 1972 | 641 | 0.010 |
Why?
|
Diet | 1 | 2009 | 7923 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1967 | 4029 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2006 | 4229 | 0.010 |
Why?
|
Propanolamines | 1 | 1991 | 167 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1967 | 4823 | 0.010 |
Why?
|
Uterine Rupture | 1 | 1970 | 72 | 0.010 |
Why?
|
Spirometry | 1 | 1972 | 862 | 0.010 |
Why?
|
Magnetics | 1 | 1972 | 609 | 0.010 |
Why?
|
Fetal Heart | 1 | 1970 | 276 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1991 | 585 | 0.010 |
Why?
|
Placebos | 1 | 1993 | 1677 | 0.000 |
Why?
|
Administration, Cutaneous | 1 | 1990 | 711 | 0.000 |
Why?
|
Psychophysiology | 1 | 1968 | 135 | 0.000 |
Why?
|
Actuarial Analysis | 1 | 1987 | 377 | 0.000 |
Why?
|
Neurophysiology | 1 | 1968 | 142 | 0.000 |
Why?
|
Injections, Intra-Arterial | 1 | 1967 | 193 | 0.000 |
Why?
|
Epinephrine | 1 | 1970 | 793 | 0.000 |
Why?
|
Umbilical Arteries | 1 | 1967 | 75 | 0.000 |
Why?
|
Bacteriology | 1 | 1946 | 10 | 0.000 |
Why?
|
Vagina | 1 | 1972 | 825 | 0.000 |
Why?
|
Respiratory Tract Diseases | 1 | 1972 | 722 | 0.000 |
Why?
|
Genital Neoplasms, Female | 1 | 1972 | 516 | 0.000 |
Why?
|
Oscillometry | 1 | 1967 | 147 | 0.000 |
Why?
|
Electrocoagulation | 1 | 1967 | 158 | 0.000 |
Why?
|
Phenols | 1 | 1970 | 501 | 0.000 |
Why?
|
Uterine Inertia | 1 | 1966 | 29 | 0.000 |
Why?
|
Diazepam | 1 | 1967 | 205 | 0.000 |
Why?
|
Patients | 1 | 1993 | 892 | 0.000 |
Why?
|
Abdomen | 1 | 1972 | 1107 | 0.000 |
Why?
|
Umbilical Cord | 1 | 1967 | 180 | 0.000 |
Why?
|
Water Microbiology | 1 | 1946 | 117 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1967 | 548 | 0.000 |
Why?
|
Fungi | 1 | 1968 | 327 | 0.000 |
Why?
|
Autonomic Nervous System | 1 | 1990 | 671 | 0.000 |
Why?
|
Vaginal Smears | 1 | 1967 | 511 | 0.000 |
Why?
|
Viruses | 1 | 1968 | 374 | 0.000 |
Why?
|
Aorta, Abdominal | 1 | 1967 | 645 | 0.000 |
Why?
|
Vaccines | 1 | 1972 | 817 | 0.000 |
Why?
|
Prednisone | 1 | 1967 | 1567 | 0.000 |
Why?
|
Progesterone | 1 | 1967 | 773 | 0.000 |
Why?
|
Infertility, Female | 1 | 1967 | 784 | 0.000 |
Why?
|
Tomography, Emission-Computed | 1 | 1983 | 1144 | 0.000 |
Why?
|
Water | 1 | 1946 | 1388 | 0.000 |
Why?
|
Delivery, Obstetric | 1 | 1967 | 904 | 0.000 |
Why?
|
Gestational Age | 1 | 1967 | 3490 | 0.000 |
Why?
|
Cardiac Pacing, Artificial | 1 | 1981 | 846 | 0.000 |
Why?
|
Bacteria | 1 | 1968 | 2102 | 0.000 |
Why?
|
Germany, West | 1 | 1972 | 13 | 0.000 |
Why?
|
Diagnostic Techniques, Surgical | 1 | 1972 | 10 | 0.000 |
Why?
|
Genital Diseases, Female | 1 | 1972 | 197 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1967 | 25575 | 0.000 |
Why?
|